FDA’s Morning After The Inauguration: No Plan B Decision
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency was unable to reach a decision on Barr’s application for an OTC switch of the emergency contraceptive by the Jan. 21 user fee date; Barr expects a decision from FDA “in the near future.”
You may also be interested in...
Plan B Headed For Behind-The-Counter Sale
FDA is understood to have decided to approve the emergency contraceptive as a new, third class of product, which would restrict access but not require a prescription.
Plan B Headed For Behind-The-Counter Sale
FDA is understood to have decided to approve the emergency contraceptive as a new, third class of product, which would restrict access but not require a prescription.
Senate Health Democrats Press FDA’s Crawford For Plan B Decision Timeline
Senate Health Committee Democrats are asking to meet with FDA Commissioner nominee Lester Crawford to discuss the Rx-to-OTC switch of Barr's emergency contraceptive Plan B prior to voting on his nomination